Abstract
Task-specific focal dystonia is characterized by muscle contraction(s) during a specific task, resulting in abnormal postures or movements. Specifically, writer’s cramp involves the upper extremity during the act of writing. Musician’s dystonia has a highly variable presentation, and thus makes therapeutic options more limited. Treatments include oral pharmacologic agents, neuromodulation, surgery and, most often, botulinum toxin (BoNT) injection. Selection of target muscles for toxin injection continues to be an area of active research for these task-specific movements. We present a review of the literature selected from a predefined search of the MEDLINE and ClinicalTrials.gov databases. We include six controlled studies of botulinum toxin for the management of writer’s cramp and focal task-specific dystonia (FTSD), including musician’s dystonia. Overall, 139 patients were included across all studies, with 99 individuals injected for writer’s cramp and the remaining 40 individuals with FTSD. The age range of all patients was 18–80 years old. We included studies that utilized only the BoNT-A serotype. These studies utilized various severity scales to quantify response to toxin injection, with ratings of instrument or pen control included as subjective ratings. Of the included 139 patients in this review, pooled data for toxin response show that 73% of patients who received the drug demonstrated improvement. Specific techniques for muscle localization and targeting were difficult to study as variable methods were employed. This remains an area of ongoing exploration.
Highlights
Dystonia is characterized by sustained or intermittent muscle contractions causing abnormal, typically repetitive movements, postures or both [1]
In 1992, Yoshimura et al performed a placebo-controlled, blinded study to investigate the efficacy of botulinum toxin (BoNT)-A in focal limb dystonia
BoNT-A injections should be considered as an integral therapeutic option for the management of focal task-specific dystonia, especially in individuals who have demonstrated lack of benefit or adverse side effects with oral pharmacologic agents
Summary
Dystonia is characterized by sustained or intermittent muscle contractions causing abnormal, typically repetitive movements, postures or both [1]. Dystonia is classified into focal, multifocal, generalized, segmental or hemi-dystonia [2]. This review will focus on the utility of botulinum toxin (BoNT) in the management of task-specific focal dystonia,. Task specificity refers to the occurrence of the dystonic movements or posturing within the context of a specific pattern(s) of movement [3]. BoNT injection is presently the most effective therapy for the management of focal taskspecific dystonia. We include a review of six selected controlled studies demonstrating efficacy of BoNT
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.